Article
CysLTR1 Promoter Polymorphism and Requirement for Leukotriene Receptor Antagonist in Aspirin-Intolerant Asthma Patients
1 Sept 2007
Abstract excerpt
OBJECTIVES: Leukotriene receptor antagonists (LTRA), such as montelukast, have been used as a first-line treatment for patients with aspirin-intolerant asthma (AIA). This study evaluated associations between the clinical requirement for LTRA and genetic polymorphisms of the ALOX5, LTC4S, COX-2, CysLTR1 and TBXA2R genes in the arachidonic acid cascade in the long-term management of 89 AIA patients from a Korean...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
